These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 12116558)

  • 21. [Dual platelet inhibition with clopidogrel and ASS. Who profits from the combination?].
    MMW Fortschr Med; 2003 Jul; 145(27-28):64. PubMed ID: 14587200
    [No Abstract]   [Full Text] [Related]  

  • 22. Comparison between aspirin combined with dipyridamole versus aspirin alone within 48 hours after ischemic stroke event for prevention of recurrent stroke and improvement of neurological function: a preliminary study.
    Chairangsarit P; Sithinamsuwan P; Niyasom S; Udommongkol C; Nidhinandana S; Suwantamee J
    J Med Assoc Thai; 2005 Nov; 88 Suppl 3():S148-54. PubMed ID: 16858953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of antiplatelet therapy in stroke prevention.
    Chesney CM
    Tenn Med; 1997 Nov; 90(11):454-5. PubMed ID: 9368453
    [No Abstract]   [Full Text] [Related]  

  • 24. Combination antiplatelet agents for secondary prevention of ischemic stroke.
    Vande Griend JP; Saseen JJ
    Pharmacotherapy; 2008 Oct; 28(10):1233-42. PubMed ID: 18823219
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dipyridamole with aspirin is better than aspirin alone in preventing vascular events after ischaemic stroke or TIA.
    Sudlow C
    BMJ; 2007 Apr; 334(7599):901. PubMed ID: 17463463
    [No Abstract]   [Full Text] [Related]  

  • 26. Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?
    Usman MH; Notaro LA; Nagarakanti R; Brahin E; Dessain S; Gracely E; Ezekowitz MD
    Am J Cardiol; 2009 Apr; 103(8):1107-12. PubMed ID: 19361598
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [High dosage acetylsalicylic acid administration for prevention of acute cerebral ischemia].
    Hartmann A
    Nervenarzt; 1995 Dec; 66(12):886-9; discussion 885. PubMed ID: 8584071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ["A.I.C.L.A." controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia. Part I: Protocol (author's transl)].
    Bousser MG; Eschwege E; Haguenau M; Lefauconnier JM; Touboul D; Touboul PJ
    Rev Neurol (Paris); 1981; 137(5):333-41. PubMed ID: 7027408
    [No Abstract]   [Full Text] [Related]  

  • 29. [Secondary prevention after ischemic stroke. High risk patients need special protection].
    MMW Fortschr Med; 2004; 146 Suppl 1():10-1. PubMed ID: 15493413
    [No Abstract]   [Full Text] [Related]  

  • 30. Prevention of secondary stroke and transient ischaemic attack with antiplatelet therapy: the role of the primary care physician [corrected].
    Kirshner HS
    Int J Clin Pract; 2007 Oct; 61(10):1739-48. PubMed ID: 17877660
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Asasantin Retard or Persantin Retard+ASA?].
    Lindberg M
    Ugeskr Laeger; 2004 Jun; 166(24):2368; author reply 2369-70. PubMed ID: 15281582
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prevention of vascular events after transient ischemic attack or cerebral infarct].
    Leys D; Cordonnier C
    Rev Prat; 2006 Sep; 56(13):1437-42. PubMed ID: 17002069
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Secondary stroke prevention with antiplatelet drugs: have we reached the ceiling?
    Diener HC
    Int J Stroke; 2006 Feb; 1(1):4-8. PubMed ID: 18706062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Emergency treatment of transient cerebral ischemia].
    Boysen G
    Ugeskr Laeger; 2008 Apr; 170(17):1475. PubMed ID: 18488296
    [No Abstract]   [Full Text] [Related]  

  • 35. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Network meta-analysis: simultaneous meta-analysis of common antiplatelet regimens after transient ischaemic attack or stroke.
    Thijs V; Lemmens R; Fieuws S
    Eur Heart J; 2008 May; 29(9):1086-92. PubMed ID: 18349026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Does early high dosage dipyridamole in prevention of secondary stroke induce cardiac events?].
    Diener HC; Darius H; Bertrand-Hardy JM; Humphreys M
    Z Kardiol; 2001 May; 90(5):348-51. PubMed ID: 11452896
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage?
    Serebruany VL; Malinin AI; Sane DC
    Am J Hematol; 2003 Apr; 72(4):280-1. PubMed ID: 12666142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MATCH results: implications for the internist.
    Lutsep HL
    Am J Med; 2006 Jun; 119(6):526.e1-7. PubMed ID: 16750967
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events.
    Gengo FM; Rainka M; Robson M; Gengo MF; Forrest A; Hourihane M; Bates V
    J Clin Pharmacol; 2008 Mar; 48(3):335-43. PubMed ID: 18223144
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.